The development of T2D involves metabolic abnormalities including insulin resistance in peripheral tissues, as well as impaired insulin synthesis and secretion due to disturbed β-cell function and loss of β-cell mass [5–7]. This evidence concerns the gene INS and type 2 diabetes mellitus.